AgentMol:用于自动药物标识和分子开发的多模型AI系统
Piotr Karabowicz1, Radosław Charkiewicz1,2, Alicja Charkiewicz3
1Department of Clinical Molecular Biology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Methods and protocols
|December 24, 2025
概括
智能AI系统AgentMol通过识别蛋白质标和生成新药候选物来加速药物发现. 它使用大型语言模型和深度学习来实现高效的分子设计和亲和预测.
科学领域:
- 计算化学是一种计算化学.
- 人工智能在药物发现中的作用
- 分子建模分子建模
背景情况:
- 药物发现是一个漫长而昂贵的任务.
- 创新的计算方法对于加速早期研究至关重要.
- 人工智能为优化目标识别和化合物开发提供了潜在的解决方案.
研究的目的:
- 介绍AgentMol,一个新的AI系统,旨在自动化和增强药物发现管道.
- 整合大型语言模型,化学语言建模和深度学习,以高效地生成和评估候选药物.
- 为人工智能驱动的分子发现提供可扩展和可解释的平台.
主要方法:
- 代理商Mol使用一个检索增强生成系统与一个大语言模型与疾病相关的目标识别.
- 基于GPT-2的化学语言模型产生了受蛋白序列条件的小分子候选物 (SMILES格式).
- 一个回归卷积神经网络 (RCNN) 预测药物标结合亲缘关系 (pKi).
- LangGraph用于系统编排,确保可扩展性和可解释性.
主要成果:
- 化学语言模型展示了高性能指标:有效性 (1.00),独特性 (0.96) 和多样性 (0.89).
- 该RCNN模型实现了强大的结合亲和关系的预测准确性,R2>0.6和Pearson的R>0.8.8.
- AgentMol成功实现了对候选药物的端到端生成和评估.
- 该系统以可访问的计算需求运行.
结论:
- "AgentMol"代表了人工智能驱动药物发现的重大进步.
- 集成的人工智能系统简化了目标识别,分子生成和亲和力预测.
- 这种方法为开发新药候选药物提供了一个实用和有效的途径.
更多相关视频
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
1.1K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.4K
相关概念视频
01:26Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
01:28Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K